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Abstract
Objectives—To describe growth patterns in infants with single ventricle physiology and
determine factors influencing growth.
Study design—Data from 230 subjects enrolled in the Pediatric Heart Network Infant Single
Ventricle Enalapril Trial were used to assess factors influencing change in weight-for-age z-score
(Δz) from study enrollment (0.7 ± 0.4 months) to pre-superior cavopulmonary connection (SCPC)
(5.1 ± 1.8 months, period 1), and pre-SCPC to final study visit (14.1 ± 0.9 months, period 2).
Predictor variables included patient characteristics, feeding regimen, clinical center, and medical
factors during neonatal (period 1) and SCPC hospitalizations (period 2). Univariate regression
analysis was performed, followed by backward stepwise regression and bootstrapping reliability to
inform a final multivariable model.
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Results—Weights were available for 197/230 subjects for period 1 and 173/197 for period 2. For
period 1, greater gestational age, younger age at study enrollment, tube feeding at neonatal
discharge, and clinical center were associated with a greater negative Δz (poorer growth) in
multivariable modeling (adjusted R2 = 0.39, p < 0.001). For period 2, younger age at SCPC and
greater daily caloric intake were associated with greater positive Δz (better growth) (R2 = 0.10, p
= 0.002).
Conclusions—Aggressive nutritional support and earlier SCPC are modifiable factors
associated with a favorable change in weight-for-age z-score.
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Growth impairment in infants with congenital heart disease is well documented, particularly
in cyanotic forms of congenital heart disease including single ventricle physiology (1–4).
Infants with cyanotic heart lesions are “stunted” with both weight and height below normal
(3). Poor growth is an important problem in infants with single ventricle physiology (5–9),
particularly prior to performance of the superior cavopulmonary connection (SCPC).
Growth impairment during early infancy is associated with adverse developmental outcome,
and increased surgical risk in this population requiring complex surgical interventions
during the first year of life. Identifying modifiable factors that impact growth may result in
improved outcomes.
The Pediatric Heart Network (PHN) completed a multicenter, randomized, placebocontrolled clinical trial of the angiotensin converting enzyme inhibitor enalapril in infants
with single ventricle physiology (ISV Trial) (10). The primary outcome measure for this
clinical trial was weight-for-age z-score at 14 months of age. Although no growth benefit
was seen in infants treated with enalapril, clinical and growth data were collected
systematically and prospectively in this large study. The purposes of this analysis were to
use this well characterized cohort of infants with single ventricle physiology to describe
growth patterns in the first 14 months of life, and to determine the influence of patientrelated factors, feeding regimen, and medical factors on growth.
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Details of the ISV Trial study design and main results have been published (10, 11). Briefly,
infants with single ventricle physiology between 1 week and 45 days of age with stable
systemic and pulmonary blood flow in whom an SCPC (bidirectional Glenn anastamosis,
bilateral bidirectional Glenn anastamosis, or hemi-Fontan procedure) was planned were
enrolled. Exclusion criteria included gestational age <35 weeks, small for gestational age
(<10th percentile), a recognizable chromosomal or phenotypic syndromes associated with
growth failure, hemodynamic instability or other contraindication to angiotensin converting
enzyme inhibitors. Subjects were enrolled at 10 centers in North America between August
2003 and May 2007. The study protocol was approved by the Institutional Review or Ethics
Board at each participating institution, and written informed consent was obtained from a
parent/guardian. This clinical trial is registered at www.clinicaltrials.gov (NCT00113087).
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Data collected at the time of study enrollment included a detailed anatomic diagnosis, age at
study enrollment, gestational age, birth weight, sex, race, and ethnicity. Socioeconomic
status (annual household income and highest grade of school completed by parent/guardian)
was collected at the 14 month visit. Anthropometric measurements (weight and height) were
made at seven time points: study enrollment, 4 days after study enrollment, 2 weeks after
enrollment, pre-SCPC, 7 days after restarting study drug following SCPC, age 10 months,
and age 14 months (11). All study coordinators performing anthropometric measurements at
PHN centers underwent training specifically designed to ensure accurate and reliable
measurements of weight and height using training modules from the Health Resources and
Service Administration Maternal and Child Health Bureau
(http://dept.washington.edu/growth/). All anthropometric measurements included in the
analysis (study enrollment, pre-SCPC, and 14 months) were performed at PHN centers.
Quality assurance measures included using dedicated, appropriately calibrated scales,
duplicate measurements, and third measurements if the first two were not in agreement
(within 0.1 kg for weight, with in 1.0 cm for height).
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Nutritional data collected at these time points included method of feeding (tube, breast,
bottle) and total daily caloric intake. Daily caloric intake was determined based on caloric
density of formula or breast milk (fortified or nonfortified (assumed 20 kcal/oz), given via
feeding tube or bottle) and the estimated volume consumed on the day prior to the study
visit as reported by the caregiver. Method of feeding was defined as follows: patients with
any type of tube feeding (nasojejunal, nasogastric, gastrostomy) were classified as tube fed;
patients with any breast feeding (actual nursing rather than receiving breast milk via a
feeding tube or bottle) were classified as breast fed, and all others were classified as bottle
fed. Total calories per day were also collected at the time of discharge following neonatal
hospitalization.
Medical and surgical data were collected from the neonatal and SCPC hospitalizations. Data
collected included type of surgery, number of concurrent surgical procedures, length of
ventilator support, length of intensive care unit stay, length of hospital stay, post-operative
complications (arrhythmia, chylothorax, prolonged chest tube drainage and pacemaker
placement), number of discharge medications, and discharge oxygen saturation. All
echocardiograms were analyzed at a single core laboratory (12).
Statistical Analysis
Two distinct physiologic states are present in infants with single ventricle physiology during
the first 14 months of life: before the SCPC when the volume-loaded single ventricle
provides both the systemic and pulmonary blood flow, and following the SCPC when the
single ventricle provides the systemic blood flow only. Comparison of the weight and height
J Pediatr. Author manuscript; available in PMC 2012 December 1.
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z-scores at enrollment and pre-SCPC, and pre-SCPC and 14 months was performed using
paired t-tests. The outcome variables assessed were change in weight-for-age z-scores: 1)
pre-SCPC minus study enrollment (period 1), and 2) final study visit at 14 months of age
minus pre-SCPC (period 2). The choice of the outcomes was informed by analyzing Lowess
non-parametric curves. All z-scores were calculated using World Health Organization
standards.
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Because there were no differences in weight or height between the treatment groups in the
ISV trial, growth data for both treatment groups, enalapril and placebo, were combined for
this analysis. Data are described as frequencies, medians with 25th and 75th percentile
values, and means with standard deviations as appropriate. Normalizing transformation was
performed for skewed variables. Because weight and height were strongly collinear, only
weight was used for regression analysis. The study population used for analysis was
restricted to those subjects with non-missing weight-for-age z-scores. Subjects with missing
weight were compared with those with non-missing weight. Univariate associations between
the outcome and each of the potential predictors were investigated first. Multivariable linear
regression analysis of each testing dataset was performed initially with all testing variables
included, to determine overall adjusted R2 for the number of included variables. Stepwise
multivariable regression was performed for the outcome, with further testing for non-linear
associations. Variable selection for final models was guided by bootstrap bagging (1000
random sample datasets) to assess reliability (percentage of random sample datasets for
which the variable was selected) for inclusion. Interactions with the predictors were not
assessed. Data analyses were performed using SAS statistical software version 9.2 (SAS
Institute Inc., Cary, NC).

Results
The clinical characteristics of the 230 subjects enrolled in the ISV trial are shown in Table I
(available at www.jpeds.com). Mean age at trial enrollment was 20.4 ± 9.0 days and 63%
had a diagnosis of hypoplastic left heart syndrome. Of the 230 subjects, 28 were withdrawn
prior to the pre-SCPC visit and 2 did not have a pre-SCPC visit. Reasons for withdrawal
included death in 15, transplant in 2, family choice in 8, physician choice in 1, lost to follow
up in 1, and other in 1. Of the remaining 200 subjects, 197 had an available weight at the
pre-SCPC visit, and formed the cohort for analysis of time period 1. There were no
differences in baseline characteristics between the 197 patients with an available weight at
the pre-SCPC visit and the 33 without an available weight.
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Of the 202 subjects not withdrawn prior to the pre-SCPC visit, 17 were withdrawn before
the final 14 month visit. Reasons for withdrawal included death in 8, transplant in 5, family
choice in 1, physician choice in 1, lost to follow up in 1, and other in 1. All of the remaining
185 subjects had weight measurements at the final 14 month visit, and 183 had an available
weight measurement at the pre-SCPC visit. There were 173 subjects who underwent an
SCPC. The remaining 10 underwent palliative procedures physiologically different from an
SCPC and were excluded from the analysis (Kawashima procedure in 5, systemic to
pulmonary artery shunt in 3, and no further palliation in 2). The 173 subjects undergoing an
SCPC with an available weight measurement at the final study visit formed the cohort for
time period 2. Of these, 130 were included in the final regression model. Patients not
included had missing values for one of the key candidate predictors, caloric intake. There
were no differences in baseline characteristics between those included in the model and
those not included.
Values for weight and height at birth and for all seven study time points are shown in Table
II (available at www.jpeds.com). The percentage of patients with weight-for-age z-score <
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−2 was 26% at the time of study enrollment, 36% pre-SCPC, and 11% at 14 months. The
pattern of growth z-scores for weight and height based on data available for each of the
seven time points is shown graphically in Figure 1 (locally weighted scatter plot smoothing
Lowess curves). Average weight-for-age z-score decreased by one standard deviation from
birth to study enrollment at 20 ± 9 days from −0.15 ± 1.06 to −1.27 ± 1.27. There was also a
decrease in weight-for-age z-score from study enrollment to the 2 week visit with no
significant further decline in weight-for-age z-score between the 2 week visit and pre-SCPC
visit. At the time of the 2 week visit 81/219 (37%) of patients were still hospitalized. Mean
weight-for-age z-scores increased after the SCPC. The weight- and height-for-age z-scores
were closely associated, with Pearson correlation coefficients of 0.78 at baseline, 0.69 at
pre-SCPC, and 0.70 at 14 months (p < 0.001 for all associations).
Figure 2 demonstrates the z-scores for weight and height at baseline, pre-SCPC, and at 14
months of age. Weight-for-age and height-for-age z-scores decreased significantly from
baseline to pre-SCPC, and then increased significantly from pre-SCPC to 14 months of age
(p < 0.01 for each paired comparison). The mean change in weight-for-age z-score for time
period 1 was −0.37 ± 1.15 (n = 197), and the mean change for time period 2 was +1.12 ±
0.89 (n = 173). The change in weight and height growth for each of the two time periods
were significantly associated (Pearson correlation coefficient 0.49 for time period 1 and 0.47
for time period 2, p < 0.001 for each).
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Period 1: Study Enrollment to Pre-SCPC
The results of univariate analysis of the relationship of predictor variables to the change in
weight-for-age z-score for time period 1 are shown in Table III. Weight-for-age z-score at
the beginning of this time period (study enrollment) was negatively associated with the
change in weight-for-age z-score (R = −0.57, p < 0.01). Although a number of variables
were associated with the outcome in univariate analysis, in the multivariable model (Table
III), only age at study enrollment, gestational age, method of feeding and clinical center
remained significant (adjusted R2 = 0.39, p < 0.001). The change in weight-for-age z-score
was less negative (better growth) in subjects who were older at the time of enrollment, born
at lower gestational age, and who received nutrition via breast feeding or bottle feeding
rather than tube feeding. There was no difference in age at enrollment among clinical
centers.
Period 2: Pre-SCPC to Final Study Visit at 14 Months of Age
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The results of univariate analysis of the relationship of predictor variables to the change in
weight-for-age z-score for time period 2 are shown in Table IV. Weight-for-age z-score at
the beginning of this time period (pre-SCPC) was negatively associated with the change in
weight-for-age z-score (R = −0.43, p < 0.01). In the final multivariable model (Table IV)
only 2 predictor variables were selected by stepwise regression: age at SCPC and daily
caloric intake per kilogram of body weight at the pre-SCPC visit (R2 = 0.10, p = 0.002). The
increase in weight-for-age z-score was greater (better growth) in subjects undergoing the
SCPC at an earlier age and in those receiving more calories per kilogram of body weight at
the time of the pre-SCPC visit.

Discussion
Growth failure is common in infants with congenital heart disease, including those with
single ventricle physiology (5, 6, 8, 9, 13). There are likely multiple mechanisms
contributing to growth failure in this population including chronic cyanosis, alterations in
energy expenditure (14, 15), inadequate caloric intake (16, 17), genetic factors (18), and
alterations in serum growth factors and growth hormone (19). It can be difficult to achieve
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adequate nutrition in neonates with single ventricle physiology who typically undergo
complex surgical palliation within the first few days to weeks of life, with further surgical
palliation within the first year of life. In fact, optimizing nutritional status has been targeted
as a key component in improving inter stage outcome in infants with hypoplastic left heart
syndrome in the Joint Council on Congenital Heart Disease Quality Improvement Task
Force’s quality improvement collaborative (20).
In our cohort the most dramatic change in weight-for-age z-score was from study enrollment
(average age 3 weeks) to the 2 week visit, with a decrease in the mean z-score of −0.36
during this time period. From the 2 week visit to the pre-SCPC visit there was no change in
mean weight-for-age z-score, suggesting growth velocity stabilized during this time period.
Growth during this inter stage period is important because poor growth and nutrition during
early infancy may adversely impact neurodevelopment (21) and surgical outcome following
the SCPC (7). At the 2 week post-enrollment study visit approximately 1/3 of patients were
still hospitalized, indicating a potential opportunity for intensive nutritional intervention.
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Previous single center, retrospective studies have investigated the predictors of poor weight
gain in infants with single ventricle physiology prior to the SCPC. In a study of 50 infants
with hypoplastic left heart syndrome, Kelleher et al found that a lower weight-for-age zscore at the time of SCPC was associated with fewer calories/ounce of enteral feeds at the
time of neonatal hospital discharge, worse right ventricular function, more frequent hospital
readmissions, and higher oxygen saturations at the time of neonatal hospital discharge (5).
Anderson et al (13) found that subjects with a lower weight-for-age z-score at neonatal
hospital discharge and non-Caucasian race had a lower weight-for-age z-score at the time of
the SCPC, and that lower average daily weight gain from neonatal discharge to SCPC was
associated with formula feeding at neonatal discharge, a higher mean pulmonary arterial
pressure, and higher systemic oxygen saturation. In both of these studies the absolute
weight-for-age z-score was the outcome variable rather than the change in weight-for-age zscore used in our study.
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In ourmulticenter study, multivariable modeling demonstrated that there was less of a
decrease in weight-for-age z-score prior to the SCPC in those patients who were of younger
gestational age, older at the time of study enrollment, and receiving nutrition via breast
feeding or bottle feeding rather than tube feeding. The clinical center also was significant in
the multivariable analysis. The fact that the greatest decline in weight-for-age z-score is seen
early during the neonatal period is the likely explanation for the first two findings. Those
patients who were older at the time of enrollment likely had a decrease in weight-for-age zscore prior to study enrollment, therefore, less of a change than those enrolled earlier, and
those of younger gestational age were also likely smaller with less potential for decline in
weight-for-age z-score. Growth failure was less prominent in breast or bottle fed infants,
suggesting that they may have been healthier than the tube fed infants. Supplementation
with tube feeds did not mitigate growth failure, suggesting either increased metabolic
demand in this subset of patients, inadequate net caloric intake, perhaps due to inadequate
adjustment of feeding volume during follow-up, or a combination of both. Approaches to
nutritional support in this population vary among clinical centers, and our findings suggest
that feeding and nutritional practices at some centers may result in better weight gain.
Careful nutritional evaluation with a detailed history of caloric intake and appropriate
adjustments in feeding, particularly in infants receiving supplemental nutrition via tube
feeding, may result in improved growth in these patients. It is interesting to note that a
diagnosis of hypoplastic left heart syndrome, ventricular dysfunction, and severity of
atrioventricular valve regurgitation were not associated with the change in z-score prior to
the SCPC in multivariable analysis.
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Following the SCPC, there was a gradual increase in the mean weight-for-age z-score to a
mean improvement of over one standard deviation in our cohort at 14 months of age. A
greater increase in weight-for-age z-score was seen in those patients who were receiving a
higher daily caloric intake per kilogram of body weight at the time of the pre-SCPC visit and
those who underwent SCPC at a younger age, although this model explained only about
10% of the variance in change in z-score for this time period. A likely explanation for the
low variance explained by this model is that the favorable change in hemodynamics that
occurs with the decrease in volume load on the single ventricle overwhelms most other
factors. We found a fairly strong negative association between the weight pre-SCPC and the
increase in weight-for-age z-score suggesting those patients with the worst growth may
benefit most from an earlier SCPC.
Higher average daily caloric intake per kilogram of body weight pre-SCPC was also an
important predictor of improved weight gain following the SCPC. This finding highlights
the importance of maintaining nutritional support in these patients after hospital discharge
and throughout infancy. On average, the weight-for-age z-scores were much closer to the
population mean at the 14 month visit (mean z-score −0.5); however, a significant subset
remained at risk for poor growth.
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This study has some important limitations. Only patients who fulfilled the inclusion criteria,
specifically those infants with single ventricle physiology with stable systemic and
pulmonary blood flow who were doing relatively well at less than 45 days of age, were
approached for enrollment. Sicker, less stable patients who may be at the highest risk for
growth failure were not included in this study. In addition, infants with a gestational age <35
weeks and those who were small for gestational age were excluded. Patients with
recognizable genetic syndromes associated with growth failure were excluded from the ISV
trial; therefore, the influence of genetic syndromes on growth in infants with single ventricle
physiology could not be assessed. The greatest decline in weight-for-age z-score for the
study population was from birth to 2 weeks after study enrollment; however, because the
birth weight was not obtained according to our standard protocol, we chose to use the
change in weight-for-age z-score from study enrollment to pre-SCPC for analysis.
Additionally, only 130 of the 173 subjects who completed the trial had complete data and
were included in the final regression model.
Aggressive nutritional support and performance of the SCPC at a younger age are
modifiable factors associated with a favorable change in weight-for-age z-score during the
first 14 months of life in this patient population.
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Figure 1.

A. Lowess-smoothed curve and scatter plot of weight-for-age z-score vs. age in months.
B. Lowess-smoothed curve and scatter plot of height-for-age z-score vs. age in months.
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Figure 2.

Box plots of weight- and height-for-age z-scores at baseline (median age 0.6 months,
n=229), pre-SCPC (median age 4.8 months, n=197), and at 14 months (median age 14.0
months, n=185). The lower, middle, and upper edges of the box represent the 25th, 50th, and
75th percentiles, respectively. The “+” symbol represents the mean. SCPC – superior
cavopulmonary connection.
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Table 1

Patient and Medical Characteristics of 230 Patients Enrolled into ISV trial.

NIH-PA Author Manuscript

Variable

N*

Value**

Age at enrollment (days)

230

20.4 ± 9.0

Sex, male

162

70%

Gestational age (weeks)

230

38 (37, 39)

Birth weight (kg)

230

3.3 ± 0.5

White

184

80%

Black

32

14%

Other

14

6%

Hispanic

34

15%

Left

40

17%

Right

164

71%

Mixed

26

11%

Hypoplastic left heart syndrome

145

63%

Baseline AV valve regurgitation - none or mild

176

77%

Baseline systemic ventricular dysfunction - none

183

80%

Norwood type of palliative surgery

166

74%

Length of stay at palliative surgery (days)

227

27.0 (21.0, 40.0)

Length of ICU stay at palliative surgery (days)

226

13.0 (9.0, 21.0)

Bypass time at palliative surgery (minutes)

223

122.9 ± 57.3

Circulatory arrest at palliative surgery

122

76%

Tube fed

119

53%

Bottle fed

97

43%

Breast fed

10

4%

166

111.3 ± 28.0

Race

Predominant ventricular morphology

NIH-PA Author Manuscript

Palliative surgery

Feeding type (at discharge after palliative surgery)

Daily calories per kg (Kcal/day/kg, 4 days after randomization)
SCPC surgery

NIH-PA Author Manuscript

Pre-SCPC AV valve regurgitation - none or mild

144

73%

Daily calories per kg (Kcal/day/kg, at pre-SCPC visit)

151

108.0 ± 29.0

Age at SCPC surgery (days)

196

167.6 ± 55.0

Length of stay at SCPC surgery (days)

197

8.0 (6.0, 13.0)

Length of ICU stay at SCPC surgery (days)

197

4.0 (3.0, 5.0)

Post-operative arrhythmia

21

11%

Cavopulmonary anastamosis type of SCPC surgery

188

95%

*

N represents sample size for continuous variables, or number of subjects with attribute for categorical variables

**

%, mean ± sd, or median (iqr)

AV – atrioventricular; ICU – intensive care unit; SCPC – superior cavopulmonary connection.
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118
86
185

Age 10 months

Age 14 months

14.1 ± 0.9

10.0 ± 0.7

5.8 ± 1.6

5.1 ± 1.8

1.2 ± 0.4

0.8 ± 0.4

0.7 ± 0.4

0

Age
(months)

9.45 ± 1.24

8.22 ± 1.10

6.34 ± 1.08

6.06 ± 1.05

3.66 ± 0.54

3.43 ± 0.54

3.36 ± 0.54

3.27 ± 0.50

kg

160
197
118
86
185

−1.63 ± 1.14
−1.64 ± 1.18
−0.81 ± 1.13
−0.49 ± 1.11

209

−1.40 ± 1.23
−1.63 ± 1.07

229

n

−1.27 ± 1.27

−0.15 ± 1.06

z score*

75.3 ± 3.1

70.1 ± 3.4

63.7 ± 3.6

62.4 ± 3.8

52.5 ± 2.4

51.4 ± 2.4

51.1 ± 2.4

cm

All z-scores calculated using WHO standards. SCPC – superior cavopulmonary anastamosis.

197

Restart (post-SCPC)

211

Day 4 study drug

Pre-SCPC

229

Baseline

161

230

Birth

Week 2 study drug

n

Time Point

Weight

NIH-PA Author Manuscript

Weight and Height from Birth to Age 14 months

−0.93 ± 1.16

−1.12 ± 1.30

−1.27 ± 1.22

−1.29 ± 1.27

−1.29 ± 1.16

−1.17 ± 1.27

−1.05 ± 1.27

z score*

Height
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Table 3

NIH-PA Author Manuscript

Association between change in weight-for-age z-score from baseline to pre-SCPC* and patient and medical
characteristics
Univariate

Multivariable**

Variable

Parameter
Estimate

Age at enrollment (days)

0.05

<0.001

0.05

<0.001

Gestational age (weeks)

−0.27

<0.001

−0.21

<0.001

Clinical center

p

Parameter
Estimate

0.038

Feeding group

0.002

0.004

<0.001

Tube

reference

reference

Bottle

0.54

0.55

Breast

0.58

0.81

−0.89

Birth weight (kg)
Birth weight adjusted for gestational age

p

<0.001
<0.001

NIH-PA Author Manuscript

Low (percentile <30)

reference

Medium (percentile 30–70)

−0.25

High (percentile >70)

−0.88

Race

0.008

White

reference

Black

0.45

Other

−0.74

Hypoplastic left heart syndrome

−0.33

Predominant ventricular morphology

0.049
0.269

Left

−0.13

Right

−0.37

Mixed

reference

Gender, male

−0.13

0.457

Hispanic

−0.11

0.639

Baseline AVVR – none or mild

−0.06

0.748

Baseline systemic ventricular dysfunction-none

0.06

0.787

0.01

0.002

Palliative surgery

NIH-PA Author Manuscript

Daily calories per kg (Kcal/day/kg) §
Number of discharge medications

0.005

Low (<3)

0.91

Medium (3–5)

0.54

High (>5)

reference

Circulatory arrest

−0.42

0.045

Age at palliative surgery (days)

0.02

0.126

Length of hospital stay (days) †

0.18

0.241

Length of ICU stay (days) †

0.13

0.239

Concurrent procedures (number)

−0.05

0.585
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Univariate

Multivariable**
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Variable

Parameter
Estimate

Palliative surgery: crossclamp time (min)

−0.00

0.763

Palliative surgery: bypass time (min)

0.00

0.794

Discharge oxygen saturation (%)

−0.00

0.924

Type of Norwood surgery

0.02

0.916

p

Parameter
Estimate

p

*

Weight-for-age z-score at the pre-SCPC visit minus weight-for-age z-score at baseline

** 2
R = 0.31 (R2 adjusted = 0.30), p < 0.001, n = 197
§

4 days after randomization

†

After logarithmic transformation

AVVR – atrioventricular valve regurgitation; ICU- intensive care unit.
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Table 4
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Association between change in weight-for-age z-score from pre-SCPC to 14 month visit* and patient and
medical characteristics
Univariate

Multivariable**

Variable

Parameter
Estimate

p

Birth weight (kg)

−0.46

<.001

Birth weight adjusted for gestational age

Parameter
Estimate

p

0.048

Low (percentile <30)

reference

Medium (percentile 30–70)

−0.20

High (percentile >70)

−0.44

Race

0.008

White

reference

Black

−0.43

Other

0.04

NIH-PA Author Manuscript

Gestational age (wks)

−0.12

0.009

Hypoplastic left heart syndrome

0.28

0.048

Hispanic

0.17

0.378

Predominant ventricular morphology

0.399

Left

0.02

Right

0.22

Mixed

reference

Clinical center

0.662

Sex, male

0.05

0.744

Daily calories per kg (Kcal/day/kg)§

0.006

0.010

0.005

0.027

Age at SCPC surgery (days)

−0.004

0.005

−0.003

0.014

SCPC surgery

Feeding group§

0.004

Tube

reference

Bottle

0.08

Breast

−0.93

NIH-PA Author Manuscript

Post-operative arrhythmia

0.49

0.027

Total days of ventilatory support†

−0.18

0.133

AVVR§ - none or mild

−0.23

0.151

Discharge oxygen saturation (%)

−0.02

0.210

Number of interventional cardiac catheterizations

0.13

0.311

Ejection fraction, %§

−0.01

0.327

Number of discharge medications

0.338

Low (<3)

−0.19

Medium (3–5)

−0.26

High (>5)

reference

Length of ICU stay (days) †

−0.09

0.398
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Univariate

Multivariable**
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Variable

Parameter
Estimate

p

Number of concurrent cardiac surgical procedures

0.05

0.430

Total days until last chest tube removed†

−0.11

0.488

Chylous drainage

−0.08

0.732

Number of significant anatomic diagnoses

−0.01

0.861

Length of hospital stay (days)†

0.01

0.915

Number of other cardiac surgical procedures

0.00

0.960

Parameter
Estimate

p

*

Weight-for-age z-score at the 14 month visit minus weight-for-age z-score at the pre-SCPC

** 2
R = 0.10 (R2 adjusted = 0.08), p = 0.002, n = 130
§

At pre-SCPC visit

†

After logarithmic transformation

AVVR – overall atrioventricular valve regurgitation; SCPC – superior cavopulmonary anastamosis.
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